QCG
IDYA icon

Quadrant Capital Group’s IDEAYA Biosciences IDYA Stock Holding History

Quadrant Capital Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,563
Closed -$52.1K – 1862
2026
Q1 		$52.1K Hold
1,563
– – ﹤0.01% 1685
2025
Q4 		$54K Hold
1,563
– – ﹤0.01% 1657
2025
Q3 		$42.5K Buy
+1,563
New +$37.8K ﹤0.01% 1727
2025
Q2 		– Sell
-1,703
Closed -$27.9K – 1933
2025
Q1 		$27.9K Buy
1,703
+1,430
+524% +$30.5K ﹤0.01% 1926
2024
Q4 		$7.02K Sell
273
-196
-42% -$5.55K ﹤0.01% 2224
2024
Q3 		$14.9K Hold
469
– – ﹤0.01% 2015
2024
Q2 		$16.5K Sell
469
-236
-33% -$9.35K ﹤0.01% 1938
2024
Q1 		$30.9K Buy
705
+236
+50% +$10.1K ﹤0.01% 1654
2023
Q4 		$16.7K Buy
469
+280
+148% +$8.36K ﹤0.01% 1890
2023
Q3 		$5.1K Hold
189
– – ﹤0.01% 2166
2023
Q2 		$4.44K Hold
189
– – ﹤0.01% 2227
2023
Q1 		$2.6K Buy
+189
New +$3.15K ﹤0.01% 2380
2022
Q3 		– Sell
-186
Closed -$3K – 2711
2022
Q2 		$3K Buy
+186
New +$2.07K ﹤0.01% 2112

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Quadrant Capital Group's IDYA Position: Q2 2026 in Review

Quadrant Capital Group sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 1,563 shares — an estimated $52.1K sold.

Quadrant Capital Group first reported a position in IDYA in Q2 2022 and held it in 13 quarters. The position peaked at $54K in Q4 2025. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Quadrant Capital Group reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 1,563 IDEAYA Biosciences shares in Q2 2026, an estimated $52.1K.
  • Quadrant Capital Group first reported a position in IDEAYA Biosciences in Q2 2022 and held it in 13 quarters.
  • Quadrant Capital Group's IDEAYA Biosciences position peaked at $54K in Q4 2025.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.